NCT05702853 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05702853
Title	Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Medical University of South Carolina
Indications	intravascular large B-cell lymphoma marginal zone lymphoma mantle cell lymphoma Burkitt lymphoma diffuse large B-cell lymphoma follicular lymphoma lymphoplasmacytic lymphoma diffuse large B-cell lymphoma germinal center B-cell type diffuse large B-cell lymphoma activated B-cell type chronic lymphocytic leukemia/small lymphocytic lymphoma B-cell lymphoma primary mediastinal B-cell lymphoma
Therapies	CD19-CD34 CAR transduced T-cells Cyclophosphamide + Fludarabine
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Hollings Cancer Center at Medical University of South Carolina	RECRUITING	Charleston	South Carolina	29425	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05702853Clinical Trial Detail